Home   Contact Palatin   Site Map  
 

Press Releases

 
2002 2003 2004 2005 all
 
 

 


Displaying releases: 1-15 | 16-30 | 31-45 | 46-60 | 61-75 | 76-90 | 91-105 | 106-120 | 121-135 | 136-150 | 151-165 | 166-180 | 181-195 | 196-210 | 211-225 | 226-240 | 241-255 | 256-270 | 271-285 | 286-300 | 301-308


  Mar-06-2015 Palatin Technologies to Present at the 27th Annual ROTH Conference
  Feb-20-2015 Palatin Launches reconnectstudy.com in Support of Bremelanotide Phase 3 Program for Female Sexual Dysfunction
  Feb-13-2015 Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on February 13, 2015
  Feb-09-2015 Palatin Technologies, Inc. To Report Second Quarter Fiscal Year 2015 Results Teleconference and Webcast to be held on February 13, 2015
  Feb-06-2015 PALATIN TECHNOLOGIES TO PRESENT AT THE BIO CEO & INVESTOR CONFERENCE
  Dec-29-2014 Palatin Announces Start of Bremelanotide Phase 3 Program For Female Sexual Dysfunction
  Dec-24-2014 Palatin Completes $20 Million Equity and $10 Million Debt Financings
  Nov-18-2014 Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on November 18, 2014
  Nov-13-2014 Palatin Technologies, Inc. To Report First Quarter Fiscal Year 2015 Results
  Oct-08-2014 Palatin Technologies To Present At The 13th Annual Bio Investor Forum
  Sep-09-2014 Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2014 Results
  Sep-04-2014 Palatin Technologies, Inc. To Report Fourth Quarter and Fiscal Year 2014 Results Teleconference and Webcast to be held on September 9, 2014
  Sep-03-2014 Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter
  Jul-09-2014 Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
  Jun-27-2014 Palatin Technologies to Join Russell Microcap Index